Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 73

1.

Di-ethylhexylphthalate (DEHP) modulates cell invasion, migration and anchorage independent growth through targeting S100P in LN-229 glioblastoma cells.

Sims JN, Graham B, Pacurari M, Leggett SS, Tchounwou PB, Ndebele K.

Int J Environ Res Public Health. 2014 May 9;11(5):5006-19. doi: 10.3390/ijerph110505006.

2.

Targeting S100P inhibits colon cancer growth and metastasis by Lentivirus-mediated RNA interference and proteomic analysis.

Jiang L, Lai YK, Zhang J, Wang H, Lin MC, He ML, Kung HF.

Mol Med. 2011;17(7-8):709-16. doi: 10.2119/molmed.2011.00008. Epub 2011 Feb 9.

3.

S100P promotes pancreatic cancer growth, survival, and invasion.

Arumugam T, Simeone DM, Van Golen K, Logsdon CD.

Clin Cancer Res. 2005 Aug 1;11(15):5356-64.

4.

Functional evidence implicating S100P in prostate cancer progression.

Basu GD, Azorsa DO, Kiefer JA, Rojas AM, Tuzmen S, Barrett MT, Trent JM, Kallioniemi O, Mousses S.

Int J Cancer. 2008 Jul 15;123(2):330-339. doi: 10.1002/ijc.23447.

5.

Overexpression of CD97 confers an invasive phenotype in glioblastoma cells and is associated with decreased survival of glioblastoma patients.

Safaee M, Clark AJ, Oh MC, Ivan ME, Bloch O, Kaur G, Sun MZ, Kim JM, Oh T, Berger MS, Parsa AT.

PLoS One. 2013 Apr 26;8(4):e62765. doi: 10.1371/journal.pone.0062765. Print 2013.

7.

S100P is Overexpressed in Squamous Cell and Adenosquamous Carcinoma Subtypes of Endometrial Cancer and Promotes Cancer Cell Proliferation and Invasion.

Jiang H, Hu H, Lin F, Lim YP, Hua Y, Tong X, Zhang S.

Cancer Invest. 2016 Nov 25;34(10):477-488. Epub 2016 Oct 24.

PMID:
27918216
8.

Knockdown of S100P by lentiviral-mediated RNAi promotes apoptosis and suppresses the colony-formation ability of gastric cancer cells.

Zhang Q, Hu H, Shi X, Tang W.

Oncol Rep. 2014 May;31(5):2344-50. doi: 10.3892/or.2014.3104. Epub 2014 Mar 21.

PMID:
24677114
9.

The emerging role of tumor-suppressive microRNA-218 in targeting glioblastoma stemness.

Gao X, Jin W.

Cancer Lett. 2014 Oct 10;353(1):25-31. doi: 10.1016/j.canlet.2014.07.011. Epub 2014 Jul 17. Review.

PMID:
25042866
10.

MicroRNA-377 inhibited proliferation and invasion of human glioblastoma cells by directly targeting specificity protein 1.

Zhang R, Luo H, Wang S, Chen W, Chen Z, Wang HW, Chen Y, Yang J, Zhang X, Wu W, Zhang SY, Shen S, Dong Q, Zhang Y, Jiang T, Lu D, Zhao S, You Y, Liu N, Wang H.

Neuro Oncol. 2014 Nov;16(11):1510-22. doi: 10.1093/neuonc/nou111. Epub 2014 Jun 20.

11.

B-cell lymphoma/leukemia 10 promotes oral cancer progression through STAT1/ATF4/S100P signaling pathway.

Wu TS, Tan CT, Chang CC, Lin BR, Lai WT, Chen ST, Kuo MY, Rau CL, Jaw FS, Chang HH.

Oncogene. 2015 Mar 5;34(10):1207-19. doi: 10.1038/onc.2014.43. Epub 2014 Mar 31. Erratum in: Oncogene. 2017 Jul 17;:.

PMID:
24681956
12.

Serine/threonine kinase 17A is a novel candidate for therapeutic targeting in glioblastoma.

Mao P, Hever-Jardine MP, Rahme GJ, Yang E, Tam J, Kodali A, Biswal B, Fadul CE, Gaur A, Israel MA, Spinella MJ.

PLoS One. 2013 Nov 28;8(11):e81803. doi: 10.1371/journal.pone.0081803. eCollection 2013.

13.

Knockdown of long non-coding RNA XIST exerts tumor-suppressive functions in human glioblastoma stem cells by up-regulating miR-152.

Yao Y, Ma J, Xue Y, Wang P, Li Z, Liu J, Chen L, Xi Z, Teng H, Wang Z, Li Z, Liu Y.

Cancer Lett. 2015 Apr 1;359(1):75-86. doi: 10.1016/j.canlet.2014.12.051. Epub 2015 Jan 8.

PMID:
25578780
14.

S100P dissociates myosin IIA filaments and focal adhesion sites to reduce cell adhesion and enhance cell migration.

Du M, Wang G, Ismail TM, Gross S, Fernig DG, Barraclough R, Rudland PS.

J Biol Chem. 2012 May 4;287(19):15330-44. doi: 10.1074/jbc.M112.349787. Epub 2012 Mar 6.

15.

Analysis of the predictive efficiency of S100P on adverse prognosis and the pathogenesis of S100P-mediated invasion and metastasis of colon adenocarcinoma.

Shen ZY, Fang Y, Zhen L, Zhu XJ, Chen H, Liu H, Jiang B, Li GX, Deng HJ.

Cancer Genet. 2016 Apr;209(4):143-53. doi: 10.1016/j.cancergen.2016.02.002. Epub 2016 Feb 13.

PMID:
26975699
16.

ALG2 regulates glioblastoma cell proliferation, migration and tumorigenicity.

Zhang D, Wang F, Pang Y, Zhao E, Zhu S, Chen F, Cui H.

Biochem Biophys Res Commun. 2017 Apr 29;486(2):300-306. doi: 10.1016/j.bbrc.2017.03.032. Epub 2017 Mar 12.

PMID:
28300556
17.

Molecular regulation of S100P in human lung adenocarcinomas.

Rehbein G, Simm A, Hofmann HS, Silber RE, Bartling B.

Int J Mol Med. 2008 Jul;22(1):69-77.

PMID:
18575778
18.

Danthron inhibits the migration and invasion of human brain glioblastoma multiforme cells through the inhibition of mRNA expression of focal adhesion kinase, Rho kinases-1 and metalloproteinase-9.

Lin CC, Chen JT, Yang JS, Lu HF, Hsu SC, Tan TW, Lin YT, Ma YS, Ip SW, Wu JJ, Li YC, Chung JG.

Oncol Rep. 2009 Nov;22(5):1033-7.

PMID:
19787217
19.

NHERF-1: modulator of glioblastoma cell migration and invasion.

Kislin KL, McDonough WS, Eschbacher JM, Armstrong BA, Berens ME.

Neoplasia. 2009 Apr;11(4):377-87.

20.

FOXC2 often overexpressed in glioblastoma enhances proliferation and invasion in glioblastoma cells.

Li W, Fu X, Liu R, Wu C, Bai J, Xu Y, Zhao Y, Xu Y.

Oncol Res. 2013;21(2):111-20. doi: 10.3727/096504013X13814233062171.

PMID:
24406047

Supplemental Content

Support Center